• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.03% Nasdaq Up1.29%

    Esperion Therapeutics, Inc. (ESPR)

    -NasdaqGM
    100.40 Up 5.27(5.54%) May 1, 4:00PM EDT
    |After Hours : 99.97 Down 0.43 (0.43%) May 1, 4:33PM EDT
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):1.6
    Mean Recommendation (last week):1.6
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:124.50
    Median Target:125.50
    High Target:150.00
    Low Target:104.00
    No. of Brokers:8

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Apr 23, 2015RBC Capital MktsInitiated Outperform
    Apr 1, 2015UBSInitiated Buy
    Oct 27, 2014NeedhamInitiated Buy
    Jul 22, 2013StifelInitiated Buy
    Dec 22, 2003Fortis BankUpgradeHoldStrong Buy
    Oct 31, 2003Robert W. BairdDowngradeOutperformNeutral
    Aug 22, 2003WachoviaInitiated Outperform
    Aug 20, 2003Lehman BrothersInitiated Overweight
    Jul 8, 2003Jefferies & CoInitiated Buy
    Jun 26, 2003Robert W. BairdUpgradeNeutralOutperform

    More Upgrades & Downgrades for ESPR

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy3332
    Buy4333
    Hold0001
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.